Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department: A Prospective, Randomized, Double-blind Placebo Controlled Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02916927

Organisation Name: Alameda Health System

Overal Status: Completed

Start Date: September 2016

Last Update: April 17, 2020

Lead Sponsor: Alameda Health System

Brief Summary: Objective: The purpose of this study is to determine if administering ketamine as an intravenous (IV) infusion over 15 minutes, as compared to an IV push, will decrease adverse drug reactions without attenuating its analgesic effects.

Study design: prospective, randomized, controlled, double-blind trial.

Conditions:
  • Pain


Total execution time in seconds: 0.51566696166992